179 related articles for article (PubMed ID: 14683461)
21. PTP1B as a drug target: recent developments in PTP1B inhibitor discovery.
Zhang S; Zhang ZY
Drug Discov Today; 2007 May; 12(9-10):373-81. PubMed ID: 17467573
[TBL] [Abstract][Full Text] [Related]
22. Protein tyrosine phosphatases: the quest for negative regulators of insulin action.
Asante-Appiah E; Kennedy BP
Am J Physiol Endocrinol Metab; 2003 Apr; 284(4):E663-70. PubMed ID: 12626322
[TBL] [Abstract][Full Text] [Related]
23. Novel protein tyrosine phosphatase 1B inhibitors: interaction requirements for improved intracellular efficacy in type 2 diabetes mellitus and obesity control.
Popov D
Biochem Biophys Res Commun; 2011 Jul; 410(3):377-81. PubMed ID: 21683066
[TBL] [Abstract][Full Text] [Related]
24. Protein Tyrosine Phosphatases in Hypothalamic Insulin and Leptin Signaling.
Zhang ZY; Dodd GT; Tiganis T
Trends Pharmacol Sci; 2015 Oct; 36(10):661-674. PubMed ID: 26435211
[TBL] [Abstract][Full Text] [Related]
25. DGAT: novel therapeutic target for obesity and type 2 diabetes mellitus.
Subauste A; Burant CF
Curr Drug Targets Immune Endocr Metabol Disord; 2003 Dec; 3(4):263-70. PubMed ID: 14683457
[TBL] [Abstract][Full Text] [Related]
26. Small molecule peptidomimetics containing a novel phosphotyrosine bioisostere inhibit protein tyrosine phosphatase 1B and augment insulin action.
Bleasdale JE; Ogg D; Palazuk BJ; Jacob CS; Swanson ML; Wang XY; Thompson DP; Conradi RA; Mathews WR; Laborde AL; Stuchly CW; Heijbel A; Bergdahl K; Bannow CA; Smith CW; Svensson C; Liljebris C; Schostarez HJ; May PD; Stevens FC; Larsen SD
Biochemistry; 2001 May; 40(19):5642-54. PubMed ID: 11341829
[TBL] [Abstract][Full Text] [Related]
27. Recent Advances in Protein Tyrosine Phosphatase 1B Targeted Drug Discovery for Type II Diabetes and Obesity.
Maheshwari N; Karthikeyan C; Trivedi P; Moorthy NSHN
Curr Drug Targets; 2018; 19(5):551-575. PubMed ID: 28228082
[TBL] [Abstract][Full Text] [Related]
28. Inhibitors of protein tyrosine phosphatase 1B (PTP1B).
Taylor SD
Curr Top Med Chem; 2003; 3(7):759-82. PubMed ID: 12678843
[TBL] [Abstract][Full Text] [Related]
29. Human protein tyrosine phosphatase 1B inhibitors: QSAR by genetic function approximation.
Sachan N; Kadam SS; Kulkarni VM
J Enzyme Inhib Med Chem; 2007 Jun; 22(3):267-76, 371-3. PubMed ID: 17674807
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of the protein tyrosine phosphatase PTP1B: potential therapy for obesity, insulin resistance and type-2 diabetes mellitus.
Koren S; Fantus IG
Best Pract Res Clin Endocrinol Metab; 2007 Dec; 21(4):621-40. PubMed ID: 18054739
[TBL] [Abstract][Full Text] [Related]
31. Protein tyrosine phosphatases as drug targets: PTP1B and beyond.
Hooft van Huijsduijnen R; Wälchli S; Ibberson M; Harrenga A
Expert Opin Ther Targets; 2002 Dec; 6(6):637-47. PubMed ID: 12472377
[TBL] [Abstract][Full Text] [Related]
32. Increased hypothalamic protein tyrosine phosphatase 1B contributes to leptin resistance with age.
Morrison CD; White CL; Wang Z; Lee SY; Lawrence DS; Cefalu WT; Zhang ZY; Gettys TW
Endocrinology; 2007 Jan; 148(1):433-40. PubMed ID: 17038557
[TBL] [Abstract][Full Text] [Related]
33. A comprehensive review on the research progress of PTP1B inhibitors as antidiabetics.
Agrawal N; Dhakrey P; Pathak S
Chem Biol Drug Des; 2023 Oct; 102(4):921-938. PubMed ID: 37232059
[TBL] [Abstract][Full Text] [Related]
34. Protein tyrosine phosphatase 1B in metabolic diseases and drug development.
Delibegović M; Dall'Angelo S; Dekeryte R
Nat Rev Endocrinol; 2024 Jun; 20(6):366-378. PubMed ID: 38519567
[TBL] [Abstract][Full Text] [Related]
35. Cellular effects of small molecule PTP1B inhibitors on insulin signaling.
Xie L; Lee SY; Andersen JN; Waters S; Shen K; Guo XL; Moller NP; Olefsky JM; Lawrence DS; Zhang ZY
Biochemistry; 2003 Nov; 42(44):12792-804. PubMed ID: 14596593
[TBL] [Abstract][Full Text] [Related]
36. Natural products possessing protein tyrosine phosphatase 1B (PTP1B) inhibitory activity found in the last decades.
Jiang CS; Liang LF; Guo YW
Acta Pharmacol Sin; 2012 Oct; 33(10):1217-45. PubMed ID: 22941286
[TBL] [Abstract][Full Text] [Related]
37. Establishment of a cell-based drug screening model for identifying down-regulators of Protein Tyrosine Phosphatase 1B expression.
Lian JH; Guo L; Hu WR; Wu GL; Ji W; Gong BQ
Exp Clin Endocrinol Diabetes; 2007 Jan; 115(1):24-8. PubMed ID: 17286230
[TBL] [Abstract][Full Text] [Related]
38. Protein tyrosine phosphatase 1B inhibitors as antidiabetic agents - A brief review.
Verma M; Gupta SJ; Chaudhary A; Garg VK
Bioorg Chem; 2017 Feb; 70():267-283. PubMed ID: 28043717
[TBL] [Abstract][Full Text] [Related]
39. Prospects for inhibitors of protein tyrosine phosphatase 1B as antidiabetic drugs.
Hooft van Huijsduijnen R; Sauer WH; Bombrun A; Swinnen D
J Med Chem; 2004 Aug; 47(17):4142-6. PubMed ID: 15293983
[No Abstract] [Full Text] [Related]
40. Toward a treatment of diabesity: In vitro and in vivo evaluation of uncharged bromophenol derivatives as a new series of PTP1B inhibitors.
Li X; Xu Q; Li C; Luo J; Li X; Wang L; Jiang B; Shi D
Eur J Med Chem; 2019 Mar; 166():178-185. PubMed ID: 30711829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
